EUVIMEDEUVIMED entdecken
Crossref

Impact of the phenotypic expression of temocillin resistance in Escherichia coli on temocillin efficacy in a murine peritonitis model

Elise Mallart, François Guerin iD, Ariane Amoura, Matthieu Le Scouarnec, Antoine Hamon, Imane El Meouche, Françoise Chau, Agnès Lefort, Bruno Fantin, Vincent Cattoir iD, Victoire de Lastours iD

Journal of Antimicrobial Chemotherapy · 2024

DOI: 10.1093/jac/dkae072 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2024. Verfasst von Elise Mallart und 10 weiteren Autor:innen. Beteiligte Einrichtung: IAME Research Group, UMR1137 INSERM and Uiversité Paris Cité, F-75018 Paris, France. Hauptthemen laut MEDLINE: Peritonitis, Penicillins, Anti-Bacterial Agents, Escherichia coli. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: IAME, Fondation pour la Recherche Médicale, Assistance-Publique Hôpitaux de Paris.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Temocillin is a narrow spectrum β-lactam active against MDR Enterobacterales. Mechanisms of acquired resistance to temocillin are poorly understood. We analysed resistance mechanisms in clinical isolates of Escherichia coli and evaluated their impact on temocillin efficacy in vitro and in a murine peritonitis model.

Methods

Two sets of isogenic clinical E. coli strains were studied: a susceptible isolate (MLTEM16S) and its resistant derivative, MLTEM16R (mutation in nmpC porin gene); and temocillin-resistant derivatives of E. coli CFT073: CFT-ΔnmpC (nmpC deletion), CFTbaeS-TP and CFTbaeS-AP (two different mutations in the baeS efflux-pump gene). Fitness cost, time–kill curves and phenotypic expression of resistance were determined. Temocillin efficacy was assessed in a murine peritonitis model.

Results

MICs of temocillin were 16 and 64 mg/L for MLTEM16S and MLTEM16R, respectively, and 8, 128, 256 and 256 mg/L for E. coli-CFT073, CFT-ΔnmpC, CFTbaeS-TP and CFTbaeS-AP, respectively. No fitness cost of resistance was evidenced. All resistant strains showed heteroresistant profiles, except for CFTbaeS-AP, which displayed a homogeneous pattern. In vitro, temocillin was bactericidal against MLTEM16R, CFT-ΔnmpC, CFTbaeS-TP and CFTbaeS-AP at 128, 256, 512 and 512 mg/L, respectively. In vivo, temocillin was as effective as cefotaxime against MLTEM16R, CFT-ΔnmpC and CFTbaeS-TP, but inefficient against CFTbaeS-AP (100% mortality).

Conclusions

Heteroresistant NmpC porin alteration and active efflux modification do not influence temocillin efficacy despite high MIC values, unfavourable pharmacokinetic/pharmacodynamic conditions and the absence of fitness cost, whereas homogeneously expressed BaeS efflux pump alteration yielding similar MICs leads to temocillin inefficacy. MIC as sole predictor of temocillin efficacy should be used with caution.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PeritonitisPenicillinsAnti-Bacterial AgentsEscherichia coliMicrobial Sensitivity TestsDisease Models, AnimalEscherichia coli InfectionsAnimalsMiceDrug Resistance, BacterialFemaleTreatment OutcomePhenotypeHumans

Substanzen

temocillinPenicillinsAnti-Bacterial Agents

Autor:innen und Institutionen

  • IAME Research Group, UMR1137 INSERM and Uiversité Paris Cité, F-75018 Paris, France.
  • UMR1230, INSERM and Université Rennes 1, F-35043 Rennes, France.
  • Service de Bactériologie-Hygiène Hospitalière & CNR de la Résistance aux Antibiotiques (laboratoire associé 'Entérocoques'), CHU Pontchaillou, F-35033 Rennes, France.
  • Service de Médecine Interne, Hôpital Beaujon, AP-HP, Université Paris Cité, F-92210 Clichy, France.

ORCID-Profile: François Guerin, Vincent Cattoir, Victoire de Lastours

Förderung

  • IAME
  • Fondation pour la Recherche Médicale
  • Assistance-Publique Hôpitaux de Paris

Zitieren

APA

Mallart, E., Guerin, F., Amoura, A., Le Scouarnec, M., Hamon, A., El Meouche, I., Chau, F., Lefort, A., Fantin, B., Cattoir, V., & de Lastours, V. (2024). Impact of the phenotypic expression of temocillin resistance in Escherichia coli on temocillin efficacy in a murine peritonitis model. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkae072

Vancouver

Mallart E, Guerin F, Amoura A, Le Scouarnec M, Hamon A, El Meouche I, et al. Impact of the phenotypic expression of temocillin resistance in Escherichia coli on temocillin efficacy in a murine peritonitis model. Journal of Antimicrobial Chemotherapy. 2024. doi:10.1093/jac/dkae072

BibTeX
@article{Mallart2024,
  author = {Mallart, Elise and Guerin, François and Amoura, Ariane and Le Scouarnec, Matthieu and Hamon, Antoine and El Meouche, Imane and Chau, Françoise and Lefort, Agnès and Fantin, Bruno and Cattoir, Vincent and de Lastours, Victoire},
  title = {Impact of the phenotypic expression of temocillin resistance in Escherichia coli on temocillin efficacy in a murine peritonitis model},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2024},
  doi = {10.1093/jac/dkae072}
}
Kostenlos starten →